Literature DB >> 16697315

Renal impairment and outcomes in heart failure: systematic review and meta-analysis.

Grace L Smith1, Judith H Lichtman, Michael B Bracken, Michael G Shlipak, Christopher O Phillips, Paul DiCapua, Harlan M Krumholz.   

Abstract

OBJECTIVES: We estimated the prevalence of renal impairment in heart failure (HF) patients and the magnitude of associated mortality risk using a systematic review of published studies.
BACKGROUND: Renal impairment in HF patients is associated with excess mortality, although precise risk estimates are unclear.
METHODS: A systematic search of MEDLINE (through May 2005) identified 16 studies characterizing the association between renal impairment and mortality in 80,098 hospitalized and non-hospitalized HF patients. All-cause mortality risks associated with any renal impairment (creatinine >1.0 mg/dl, creatinine clearance [CrCl] or estimated glomerular filtration rate [eGFR] <90 ml/min, or cystatin-C >1.03 mg/dl) and moderate to severe impairment (creatinine > or =1.5, CrCl or eGFR <53, or cystatin-C > or =1.56) were estimated using fixed-effects meta-analysis.
RESULTS: A total of 63% of patients had any renal impairment, and 29% had moderate to severe impairment. After follow-up > or =1 year, 38% of patients with any renal impairment and 51% with moderate to severe impairment died versus 24% without impairment. Adjusted all-cause mortality was increased for patients with any impairment (hazard ratio [HR] = 1.56; 95% confidence interval [CI] 1.53 to 1.60, p < 0.001) and moderate to severe impairment (HR = 2.31; 95% CI 2.18 to 2.44, p < 0.001). Mortality worsened incrementally across the range of renal function, with 15% (95% CI 14% to 17%) increased risk for every 0.5 mg/dl increase in creatinine and 7% (95% CI 4% to 10%) increased risk for every 10 ml/min decrease in eGFR.
CONCLUSIONS: Renal impairment is common among HF patients and confers excess mortality. Renal function should be considered in risk stratification and evaluation of therapeutic strategies for HF patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16697315     DOI: 10.1016/j.jacc.2005.11.084

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  215 in total

1.  The coexistence of multiple cardiovascular diseases is an independent predictor of the 30-day mortality of hospitalized patients with congestive heart failure: a study in Beijing.

Authors:  Qiaoxiang Yin; Yusheng Zhao; Jiayue Li; Qiao Xue; Xingli Wu; Lei Gao; Ping He; Mei Zhu; Shiwen Wang
Journal:  Clin Cardiol       Date:  2011-05-31       Impact factor: 2.882

Review 2.  Nonthyroidal illness and the cardiorenal syndrome.

Authors:  Christiaan L Meuwese; Olaf M Dekkers; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2013-09-03       Impact factor: 28.314

3.  Impact of onset time of acute kidney injury on outcomes in patients with acute decompensated heart failure.

Authors:  Yoichi Takaya; Fumiki Yoshihara; Hiroyuki Yokoyama; Hideaki Kanzaki; Masafumi Kitakaze; Yoichi Goto; Toshihisa Anzai; Satoshi Yasuda; Hisao Ogawa; Yuhei Kawano
Journal:  Heart Vessels       Date:  2014-08-24       Impact factor: 2.037

Review 4.  Cardiorenal syndrome: still not a defined entity.

Authors:  Carlo Longhini; Christian Molino; Fabio Fabbian
Journal:  Clin Exp Nephrol       Date:  2010-02-20       Impact factor: 2.801

5.  Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension.

Authors:  Aránzazu Campo; Stephen C Mathai; Jérôme Le Pavec; Ari L Zaiman; Laura K Hummers; Danielle Boyce; Traci Housten; Hunter C Champion; Noah Lechtzin; Fredrick M Wigley; Reda E Girgis; Paul M Hassoun
Journal:  Am J Respir Crit Care Med       Date:  2010-03-25       Impact factor: 21.405

Review 6.  A perspective on diuretic resistance in chronic congestive heart failure.

Authors:  Niel Shah; Raef Madanieh; Mehmet Alkan; Muhammad U Dogar; Constantine E Kosmas; Timothy J Vittorio
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-07-20

7.  Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.

Authors:  Pupalan Iyngkaran; Merlin Thomas; William Majoni; Nagesh S Anavekar; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2012-10-31       Impact factor: 2.041

8.  Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial.

Authors:  Horng H Chen; Omar F AbouEzzeddine; Kevin J Anstrom; Michael M Givertz; Bradley A Bart; G Michael Felker; Adrian F Hernandez; Kerry L Lee; Eugene Braunwald; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2013-09-01       Impact factor: 8.790

Review 9.  Clinical implications of organ congestion in heart failure patients as assessed by ultrasonography.

Authors:  Yoshihiro Seo; Tomofumi Nakatsukasa; Seika Sai; Tomoko Ishizu; Noriko Iida; Masayoshi Yamamoto; Tomoko Machino-Ohtsuka; Yasushi Kawakami; Akihiko Nogami; Kazutaka Aonuma
Journal:  Cardiovasc Diagn Ther       Date:  2018-02

Review 10.  Epidemiology and importance of renal dysfunction in heart failure patients.

Authors:  Gregory Giamouzis; Andreas P Kalogeropoulos; Javed Butler; Georgios Karayannis; Vasiliki V Georgiopoulou; John Skoularigis; Filippos Triposkiadis
Journal:  Curr Heart Fail Rep       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.